Objective To investigate the differences in abnormal liver biochemical parameters in pregnant patients during the epidemic or non-epidemic period of coronavirus disease 2019 (COVID-19).Methods A retrospective analysis was performed for 539 pregnant women who were discharged from Department of Obstetrics, Peking University First Hospital, from October 2017 to March 2022 and had at least one abnormal liver biochemical parameter among alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transpeptidase (GGT), total bilirubin (TBil), and total bile acid. The patients in the epidemic period of COVID-19 and those in the non-epidemic period of COVID-19 were compared in terms of etiology, coagulation parameters, aminotransferases, bile acid, and renal function. The independent samples t-test was used for comparison of continuous data between two groups, and the chi-square test was used for comparison of categorical data between two groups.Results Among the patients discharged from Department of Obstetrics during the non-epidemic period of COVID-19, 262 had abnormal liver biochemical parameters, accounting for 1.46%, while 277 patients had abnormal liver biochemical parameters during the epidemic period of COVID-19, accounting for 1.73% among the patients discharged from Department of Obstetrics during the same period of time, and there was a significant difference between these two groups (χ2=3.947, P=0.047). The etiological analysis of the patients with abnormal liver biochemical parameters during the two periods showed that there was no difference in the proportion of patients with four pregnancy-specific liver diseases (hyperemesis gravidarum, preeclampsia and eclampsia, intrahepatic cholestasis of pregnancy, and acute fatty liver of pregnancy). As for the patients with abnormal liver biochemical parameters in pregnancy, there was no significant difference in the proportion of patients with normal creatinine and stimated glomerular filtration rate (eGFR) between the epidemic period and the non-epidemic period (86.78% vs 87.90%, χ2=0.141, P=0.708). The patients with ALT≥5×upper limit of normal accounted for 7.94% in the epidemic period of COVID-19 and 9.54% in the non-epidemic period (χ2=0.433, P=0.511), and the patients with severe cholestasis accounted for 7.75% in the epidemic period of COVID-19 and 9.27% in the non-epidemic period (χ2=0.392, P=0.531). The proportion of patients with obstetric bleeding during the epidemic period of COVID-19 was significantly lower than that during the non-epidemic period (14.61% vs 24.19%, χ2=489.334, P<0.001).Conclusion There is no difference in the proportion of patients with pregnancy-specific liver diseases among the patients with abnormal liver biochemical parameters in pregnancy between the epidemic period and the non-epidemic period of COVID-19, and there is no change in the proportion of patients with normal creatinine and eGFR among these patients in the epidemic period of COVID-19.
BIRKNESS-GARTMAN JE, OSHIMA K. Liver pathology in pregnancy[J]. Pathol Int, 2022, 72( 1): 1- 13. DOI: 10.1111/pin.13186.
[2]
BARTLETT AQ, VESCO KK, PURNELL JQ, et al. Pregnancy and weaning regulate human maternal liver size and function[J]. Proc Natl Acad Sci USA, 2021, 118( 48): e2107269118. DOI: 10.1073/pnas.2107269118.
[3]
MANDEL E, PECI A, CRONIN K, et al. The impact of the first, second and third waves of covid-19 on hepatitis B and C testing in Ontario, Canada[J]. J Viral Hepat, 2022, 29( 3): 205- 208. DOI: 10.1111/jvh.13637.
[4]
WU ZW, ZHENG XH, GUO JX, et al. Research progress on abnormal liver function in pregnancy[J]. Chin J Hepatol, 2019, 27( 8): 653- 656. DOI: 10.3760/cma.j.issn.1007-3418.2019.08.014.
FENG Y, LYU JQ. Investigation on the prevalence of gestational liver disease in Jiaxing area[J]. Matern Child Heath Care China, 2017, 32( 10): 2201- 2203. DOI: 10.7620/zgfybj.j.issn.1001-4411.2017.10.55.
Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Clinical management guidelines for acute fatty liver of pregnancy in China(2022)[J]. J Clin Hepatol, 2022, 38( 4): 776- 783. DOI: 10.3760/cma.j.cn112141-20210907-00499.
LI BY, YANG HX. Comparison of clinical features in antepartum and postpartum HELLP syndrome[J]. Chin J Obstet Gynecol, 2022, 57( 12): 907- 913. DOI: 10.3760/cma.j.cn112141-20220707-00444.
XU CJ, HUA KQ. Practice of obstetrics& gynecology[M]. 4th ed. Beijing: People’s Medical Publishing House, 2018.
徐丛剑, 华克勤. 实用妇产科学[M]. 4版. 北京: 人民卫生出版社, 2018.
[9]
ZHAO JM, ZHANG L, ZHAO PL, et al. Relationship between main clinical indexes and prognosis of patients with liver failure[J/CD]. Chin J Liver Dis Electron Version, 2019, 11( 1): 68- 71. DOI: 10.3969/j.issn.1674-7380.2019.01.013.
JIA JD, REN H. Wang baoen hepatology[M]. 2nd ed. Beijing: Science Press, 2022.
贾继东, 任红. 王宝恩肝脏病学[M]. 2版. 北京: 科学出版社, 2022.
[12]
OU MY, HU CX, LI YP. Relationship between serum oxidative stress level and pregnancy outcome in pregnant women with intrahepatic cholestasis of pregnancy[J]. J Clin Exp Med, 2023, 22( 17): 1877- 1881. DOI: 10.3969/j.issn.1671-4695.2023.17.023.
MURASE JE, HELLER MM, BUTLER DC. Safety of dermatologic medications in pregnancy and lactation: Part I. pregnancy[J]. J Am Acad Dermatol, 2014, 70( 3): 401.e1-14;quiz 415. DOI: 10.1016/j.jaad.2013.09.010.
[14]
BRIGGS GG, FREEMAN RK, YAFFE SJ. Drugs in pregnancy and lactation[M]. YANG HX, DUAN T. Beijing: People’s Medical Publishing House, 2008.
MU GD, LI JY, GAO YJ, et al. Identification and analysis of the risk of liver-related adverse drug reaction in pregnant women[J]. J Clin Hepatol, 2022, 38( 8): 1834- 1838. DOI: 10.3969/j.issn.1001-5256.2022.08.021.
HAN CJ, PIAO MH, HUANG Y, et al. Value of intestinal fatty acid binding protein in predicting the development and progression of acute-on-chronic liver failure[J]. J Clin Hepatol, 2024, 40(8): 1633-1638. DOI: 10.12449/JCH240820.
HAN CJ, PIAO MH, HUANG Y, et al. Value of intestinal fatty acid binding protein in predicting the development and progression of acute-on-chronic liver failure[J]. J Clin Hepatol, 2024, 40(8): 1633-1638. DOI: 10.12449/JCH240820.